Catalyst Pharmaceuticals

PriceCatalyst Pharmaceuticals

CPRX

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

Historical stock price chart and annual return over the past years

434%

5 years

% Total

CPRX
40%

5 years

Annual Return

CPRX